Butterfly Network to Participate at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 06 2024 - 8:30AM
Business Wire
March 13, 2024
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital
health company transforming care with handheld, whole-body
ultrasound and intuitive software, today announced that Joseph
DeVivo, President, Chief Executive Officer and Chairman, and
Heather Getz, Executive Vice President, Chief Financial and
Operations Officer, will participate in a fireside chat and host
one-on-one investor meetings at the Oppenheimer 34th Annual
Healthcare MedTech & Services Conference on March 13, 2024, at
8:40 am ET. The conference will be held virtually.
A webcast of the fireside chat will be available in the Events
& Presentations section of the Butterfly investor website, and
available for replay following the event until June 11, 2024.
To schedule a one-on-one meeting with Mr. DeVivo and Ms. Getz,
please reach out to your Oppenheimer representative.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a
digital health company with a mission is to democratize medical
imaging by making high-quality ultrasound affordable, easy-to-use,
globally accessible, and intelligently connected, including for the
4.7 billion people around the world lacking access to ultrasound.
Butterfly created the world's first handheld single-probe,
whole-body ultrasound system using semiconductor technology,
Butterfly iQ. The company has continued to innovate, leveraging the
benefits of Moore’s Law, to launch its second generation Butterfly
iQ+ in 2020, and third generation iQ3 in 2024 – each with increased
processing power and performance enhancements. The disruptive
technology has been recognized by TIME’s Best Inventions, Fast
Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech
Breakthrough Awards, among other accolades. With its proprietary
Ultrasound-on-Chip™ technology, intelligent software, and
educational offerings, Butterfly is paving the way to mass adoption
of ultrasound for earlier detection and remote management of health
conditions around the world. Butterfly devices are commercially
available to trained healthcare practitioners in areas including,
but not limited to, parts of Africa, Asia, Australia, Europe, the
Middle East, North America and South America; to learn more about
available countries, visit:
butterflynetwork.com/choose-your-country.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240306046860/en/
Butterfly Investors: Heather Getz Chief Financial and
Operations Officers, Butterfly investors@butterflynetwork.com
or
Neal Nagarajan IR Agency Representative, Sloane & Company
(301) 273-5662 nnagarajan@sloanepr.com
Butterfly Network (NYSE:BFLY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Butterfly Network (NYSE:BFLY)
Historical Stock Chart
From Oct 2023 to Oct 2024